13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. | J Natl Cancer Inst;84(4): 241-5, 1992 Feb 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

Lippman, S M; Kavanagh, J J; Paredes-Espinoza, M; Delgadillo-Madrueño, F; Paredes-Casillas, P; Hong, W K; Holdener, E; Krakoff, I H.

Affiliation

Lippman SM; Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

J Natl Cancer Inst ; 84(4): 241-5, 1992 Feb 19.

Article in En | MEDLINE | ID: mdl-1734085

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Uterine Cervical Neoplasms Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1992 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Uterine Cervical Neoplasms Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1992 Document type: Article Country of publication: